Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 1, 2005, Pages 8-13

  Bos, Romain ^a   Mougenot, Nathalie ^a   Findji, Laurent ^a   Médiani, Odile ^a   Vanhoutte, Paul M ^b   Lechat, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aldosterone antagonist; Angiotensin II antagonist; Cardiac fibrosis; Myocardial infarction; adrenergic stimulation

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR; CANRENOATE POTASSIUM; CATECHOLAMINE; ISOPRENALINE; LOSARTAN; MINERALOCORTICOID;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CELL NUCLEUS; CONTROLLED STUDY; EVALUATION; GENE ACTIVATION; GENE CONTROL; HEART ATRIUM; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 11144347913     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200501000-00003     Document Type: Article

References (33)

1. Weber KT, Brilla CG, Campbell SE, et al. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol. 1993;88(Suppl 1):107-124.
2. Schorb W, Booz GW, Dostal DE, et al. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993;72:1245-1254.
3. Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem. 1998;273:4883-4891.
4. The Cardiac Insufficiency Bisoprolol Study II. (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
5. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Effect of metoprolol CR/XL in chronic heart failure. Lancet. 1999;353:2001-2007.
6. Randomized Aldactone Evaluation Study [RALES]. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. Am J Cardiol. 1996;78:902-907.
7. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
8. Capponi AM, Vallotton MB. Renin release by rat kidney slices incubated in vitro. Role of sodium and of alpha- and beta-adrenergic receptors, and effect of vincristine. Circ Res. 1976;39:200-203.
9. 3H-noradrenaline from the rabbit hypothalamus. Eur J Pharmacol. 1979;56:173-176.
10. Bos R, Mougenot N, Mediani O, et al. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat. J Pharmacol Exp Ther. 2004;309:1160-1166.
11. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
12. Brouri F, Findji L, Mediani O, et al. Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulation. Eur J Pharmacol. 2002;456:69-75.
13. Farivar RS, Crawford DC, Chobanian AV, et al. Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart. Hypertension. 1995;25:809-813.
14. Anthonio RL, van Veldhuisen DJ, van Gilst WH. Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both? J Cardiovasc Pharmacol. 1998;32(Suppl 1):S1-S8.
15. Grimm D, Elsner D, Schunkert H, et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res. 1998;37:91-100.
16. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985;17:291-306.
17. Bindoli A, Rigobello MP, Deeble DJ. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med. 1992;13:391-405.
18. Remiao F, Carmo H, Carvalho F, et al. Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress. Cardiovasc Toxicol. 2001;1:195-204.
19. Robert V, Van Thiem N, Cheav SL, et al. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension. 1994; 24:30-36.
20. Ramirez-Gil JF, Delcayre C, Robert V, et al. In vivo left ventricular function and collagen expression in aldosterone/salt-induced hypertension. J Cardiovasc Pharmacol. 1998;32:927-934.
21. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.
22. Delyani JA. Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney Int. 2000;57:1408-1411.
23. Barki-Harrington L, Luttrell LM, Rockman HA. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation. 2003;108: 1611-1618.
24. Robert V, Heymes C, Silvestre JS, et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension. 1999;33:981-986.
25. Alnemri ES, Maksymowych AB, Robertson NM, et al. Overexpression and characterization of the human mineralocorticoid receptor. J Biol Chem. 1991;266:18072-18081.
26. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994;63:451-486.
27. Parrelli JM, Meisler N, Cutroneo KR. Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. Int J Biochem Cell Biol. 1998;30:623-627.
28. Meisler N, Shull S, Xie R, et al. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes. J Cell Biochem. 1995;59:376-388.
29. Perez JR, Shull S, Gendimenico GJ, et al. Glucocorticoid and retinoid regulation of alpha-2 type I procollagen promoter activity. J Cell Biochem. 1992;50:26-34.
30. Ichiki T, Kambayashi Y, Inagami T. Transcription of the rat angiotensin II type 2 receptor gene. Biochem Biophys Res Commun. 1996;222:566-571.
31. Uno S, Guo DF, Nakajima M, et al. Glucocorticoid induction of rat angiotensin II type 1A receptor gene promoter. Biochem Biophys Res Commun. 1994;204:210-215.
32. Bai Y, Kirigiti P, Li X, et al. UV cross-linking/immunoprecipitation assay: glucocorticoid receptor-adrenergic receptor gene sequence interaction. Biotechniques. 2003;35:100-104, 6, 8-11.
33. Lombes M, Binart N, Oblin ME, et al. Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements. Biochem J. 1993;292:577-583.